(1)
Homšek, A.; Jovanović, M.; Miljković, B.; Vučićević, K. Assessment of Pembrolizumab Exposure in Different Patient Subpopulations Using Pharmacometric Simulation. arhfarm 2022, 72 (Suppl. 4), S227-S228.